🇺🇸
Eli Lilly’s $100B incretin opportunity: Is more upside coming?
Source: investing
Country: United States
Global Economic Intelligence
🇺🇸
Eli Lilly’s $100B incretin opportunity: Is more upside coming?
Source: investing
Country: United States